TMCI - Kewajiban jangka dawa perusahaan Treace Medical Concepts Inc

Logo grafis Treace Medical Concepts Inc (TMCI)

The visualized price action of Treace Medical Concepts (TMCI) correlates with the modernization of production capacities and high plant utilization. Treace Medical Concepts (TMCI) generates revenue from its unique Lapiplasty system for correcting foot deformities, leveraging low demand elasticity. Long-term success relies on physician adoption of new methodologies and the stability of insurance reimbursements, with the indicator standing at 0.07.

Utang jangka dawa perusahaan: Treace Medical Concepts (TMCI) kanggo 04.07.2022 - 29.10.2026
Produk sing diprodhuksi Treace Medical Concepts

High marketing expenses and surgeon training costs amid fierce competition create profitability risks for Treace Medical Concepts (TMCI). Analyzing the company's long-term debt chart, an investor sees a combination of liabilities with maturities exceeding one year. This metric measures the debt load, allowing for an assessment of the capital structure's stability and the cost of debt service. The stability of this indicator determines the overall financial reliability of the asset.

Karo sapa Treace Medical Concepts saingan

bostonscientific.com (BSX) - Utang jangka dawa|Edwards Lifesciences Corporation - Utang jangka dawa perusahaan|ResMed Inc (RMD) - Kewajiban jangka dawa perusahaan|PODD: Utang jangka dawa perusahaan|ZBH - Gunggunge utang jangka dawa|COO (The Cooper Companies) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan aligntech.com|Utang jangka dawa perusahaan Globus Medical (GMED)|Utang jangka dawa perusahaan TMDX (TransMedics Group)|Utang jangka dawa perusahaan ATEC (ATEC Spine)|Gunggunge utang jangka dawa Artivion Corp (AORT)|ENOV: Kewajiban jangka dawa perusahaan|Kewajiban jangka dawa IART|ESTA: Utang jangka dawa perusahaan|Utang jangka dawa Beta Bionics, Inc. (BBNX)|IRMD (Iradimed) - Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan EMBC (Embecta Health)|Kewajiban jangka dawa perusahaan TNDM (Tandem Diabetes Care)|AXGN (axogeninc.com) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan SI-BONE SIBN|OFIX - Kewajiban jangka dawa perusahaan|Bioventus Corp - Utang jangka dawa perusahaan|Utang jangka dawa OrthoPediatrics Corp.|SRTA: Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan CARL|RXST (RxSight) - Utang jangka dawa perusahaan|ClearPoint (CLPT) - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan STXS|Kewajiban jangka dawa perusahaan Neuronetics, Inc STIM|Utang jangka dawa perusahaan SGHT (Sight Sciences, Inc.)|Utang jangka dawa perusahaan Orchestra BioMed Inc. OBIO|ANIK - Utang jangka dawa perusahaan|NSPR: Utang jangka dawa perusahaan|ZJYL (zhjmedical.com) - Kewajiban jangka dawa perusahaan|Vivani Medical - Silihan lan utang jangka dawa perusahaan|XTNT (Xtant Medical Holdings, Inc.) - Utang jangka dawa perusahaan|Utang jangka dawa n1mtc.com NMTC|Utang jangka dawa perusahaan Modular Medical (MODD)|Myomo Inc. (MYO) - Tanggungan jangka dawa|Envoy Medical, Inc - Kewajiban jangka dawa perusahaan|Utang jangka dawa perusahaan Vivos Therapeutics Inc VVOS|enVVeno Medical - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa Sintx Technologies SINT|Tenon Medical (TNON) - Utang jangka dawa perusahaan|Kewajiban jangka dawa LFWD (ReWalk Robotics)|Utang jangka dawa perusahaan Autonomix Medical Inc.|Kewajiban jangka dawa perusahaan INVO Fertility Corp (IVF)|Utang jangka dawa perusahaan BBLG|AXNX - Utang jangka dawa|Utang jangka dawa perusahaan BIOLASE BIOL|DYNT: Tanggungan utang jangka dawa perusahaan|FNA: Kewajiban jangka dawa perusahaan|INVO Bioscience, Inc. - Gedhene kewajiban jangka dawa